Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Factors associated with exacerbations in patients with COPD: NOVELTY study

Hana Müllerová, Bo Ding, Eleni Rapsomaniki, Richard Beasley, J Mark Fitzgerald, Tim Harrison, Rod Hughes, Jose Maria Olaguibel, Helen K Reddel, Precil Varghese, Mohsen Sadatsafavi, Christer Janson
European Respiratory Journal 2020 56: 2474; DOI: 10.1183/13993003.congress-2020.2474
Hana Müllerová
1AstraZeneca, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hana.muellerova@astrazeneca.com
Bo Ding
2AstraZeneca, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleni Rapsomaniki
1AstraZeneca, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Beasley
3Medical Research Institute of New Zealand, Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Mark Fitzgerald
4Centre for Heart and Lung Health, The Lung Centre Vancouver General Hospital, UBC Institute for Heart and Lung Health, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Harrison
5Faculty of Medicine and Health Sciences, Nottingham City Hospital, Nottingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rod Hughes
1AstraZeneca, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose Maria Olaguibel
6Severe Asthma Unit, Complejo Hospitalario de Navarra, Pamplona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen K Reddel
7Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Precil Varghese
8AstraZeneca, Gaithersburg, MD, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohsen Sadatsafavi
9Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christer Janson
10Department of Medical Sciences, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Background: NOVELTY (NCT02760329) is a global, prospective, observational study of patients with physician-assigned asthma and/or COPD. At baseline, physicians were asked: “During the past 12 months, on how many occasions has your patient experienced an exacerbation of their asthma or COPD beyond the patient's usual day to day variance?”

Objective: To describe factors associated with exacerbations in patients with a physician label of COPD (± asthma) enrolled in NOVELTY.

Methods: Patients in the NOVELTY baseline cohort were categorised by exacerbation history in the 12 months prior to baseline, with analysis limited to exacerbations that were moderate (managed with oral corticosteroids and/or antibiotics, or an emergency department visit) or severe (required hospital admission).

Results: Overall, 5,072 patients had COPD (mean age 66 years, 41% female, mean post-bronchodilator FEV1 64% predicted); 16% reported 1 moderate exacerbation only (Table). Patients with exacerbations were more likely to have concomitant asthma, comorbidities, greater airflow limitation, poorer health status, more missed days of work and more impairment of work due to ill health vs patients without exacerbations.

Conclusions: Patients with COPD and a history of exacerbations (even those with only one moderate exacerbation) had a considerably higher disease burden than those without exacerbations, including more work impairment and use of more healthcare resources.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

  • COPD - exacerbations

Footnotes

Cite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 2474.

This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2020
Previous
Back to top
Vol 56 Issue suppl 64 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Factors associated with exacerbations in patients with COPD: NOVELTY study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Factors associated with exacerbations in patients with COPD: NOVELTY study
Hana Müllerová, Bo Ding, Eleni Rapsomaniki, Richard Beasley, J Mark Fitzgerald, Tim Harrison, Rod Hughes, Jose Maria Olaguibel, Helen K Reddel, Precil Varghese, Mohsen Sadatsafavi, Christer Janson
European Respiratory Journal Sep 2020, 56 (suppl 64) 2474; DOI: 10.1183/13993003.congress-2020.2474

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Factors associated with exacerbations in patients with COPD: NOVELTY study
Hana Müllerová, Bo Ding, Eleni Rapsomaniki, Richard Beasley, J Mark Fitzgerald, Tim Harrison, Rod Hughes, Jose Maria Olaguibel, Helen K Reddel, Precil Varghese, Mohsen Sadatsafavi, Christer Janson
European Respiratory Journal Sep 2020, 56 (suppl 64) 2474; DOI: 10.1183/13993003.congress-2020.2474
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Can Exhaled Nitric Oxide Be a Biomarker for Hospitalized and Post-COVID-19 Patients?
  • Prospective biochemical and hematological markers to differentiation severe from non-severe COVID-19 disease
  • Late Breaking Abstract - Development of a multivariate model for clinical prediction in COVID 19 infected patients
Show more Clinical problems

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society